We're looking forward to sharing an update on the progress of #GBMAGILE at #ESMO24! 🧠 Join us on Monday, Sept 16 for the poster session with Dr. Michael Weller, GBM AGILE Regional PI, Europe. #innovation #clinicaltrial #glioblastoma
Global Coalition for Adaptive Research
Forschung
Larkspur, CA 8,137 followers
Accelerating the discovery and development of treatments for patients with rare and deadly diseases
Über uns
The Global Coalition for Adaptive Research (GCAR) unites physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma, health authorities, and other key stakeholders in healthcare to expedite the discovery and development of treatments for patients with rare and deadly diseases. As Sponsor of innovative trials, including master protocols and adaptive platform trials, GCAR is dedicated to the advancement of science by modernizing clinical trials that support more efficient, less costly drug development. Adaptive platform trials deliver an unmatched accelerated time from discovery in the lab to implementation in the clinic resulting in better treatments and lives saved.
- Website
-
http://www.gcaresearch.org
External link for Global Coalition for Adaptive Research
- Industrie
- Forschung
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Larkspur, CA
- Typ
- Nonprofit
- Gegründet
- 2017
- Spezialitäten
- Adaptive Platform Trials, Glioblastoma GBM, Development of Cures for Patients with Rare and Deadly Diseases, Cancer Research, Cancer Policy, Clinical Trials, Cancer Treatment, Patient Information, Medical Research and Development, Funding Innovative Brain Cancer Research, Global Research Collaboration, Fundraising, and Advocacy
Standorte
-
Primäre
Wegbeschreibung erhalten
Larkspur, CA 94939, US
Employees at Global Coalition for Adaptive Research
-
Faramarz Yousefzadeh
WattEV, Canon Equity, GCAR, and Windmill Capital
-
Web Cavenee
Director Emeritus at Ludwig Institute; Professor at UCSD
-
Ashley A. Powell PhD
Vice President, Trial Operations at Global Coalition for Adaptive Research
-
Matthew Viva
Director, Legal at Global Coalition for Adaptive Research
Aktualisierungen
-
Global Coalition for Adaptive Research reposted this
Another great opportunity to learn more about Adaptive Clinical Trial Designs and Response Adaptive Randomization. Access the free module below!
▶️ In Module 4 of our adaptive #clinicaltrial designs series, experts Sofia S. Villar, Carole Mitnick, Matteo Cellamare, Lorenzo Guglielmetti and Scott Berry present: • Response adaptive randomisation (RAR) • Covariate adjusted response adaptive (CARA) randomisation • Four case studies: endTB, I-Spy 2, REMAP-CAP and ATTACC Read more and access the module for free 👉🏼 https://lnkd.in/e84G4Dy7 __________ The Ecraid Training Modules on Adaptive Clinical Trial Designs are supported by the EU-funded #ECRAIDBase project 🇪🇺 European Respiratory Society, University of Geneva, ESCMID - European Society of Clinical Microbiology and Infectious Diseases, Berry Consultants, LLC, MedStar Health, MRC Biostatistics Unit, Harvard Medical School, Médecins Sans Frontières (MSF), European Commission, Marlieke De Kraker #adaptivedesigns #clinicalresearch #adaptivetrials #education
-
-
GCAR is excited to attend #ESMO24 to provide an update on #GBMAGILE and new #clinicaltrial initiatives under development in #OvarianCancer, #PancreaticCancer, #BiliaryTractCancer, and #Neurofibromatosis – efficient, patient-centric, accelerated drug development solutions that maximize learning. With some of the world’s foremost clinical, translational, and basic science investigators and experts in developing and operationalizing master protocols and platform trials, GCAR is committed to improving outcomes for patients with rare and deadly diseases. We invite you to learn more about opportunities to partner with GCAR and meet our team. Email us at [email protected] Let's make progress #together!
-
-
September is #OvarianCancerAwarenessMonth GCAR is committed to expediting the advancement of new treatments for individuals with rare and life-threatening conditions including #ovariancancer. Our focus is on establishing #platformtrials that enhance efficiency, shorten drug testing timelines, and offer a patient-centered approach to improve patient access to new therapeutic options. To learn more about GCAR’s initiatives, visit: GCAResearch.org
-
-
A heartfelt thank you to our staff for their dedication and teamwork. We are grateful for your hard work, planning, and solution-oriented thinking which drive #GBMAGILE forward each day. Thank you to our staff past and present, collaborators, partners, and vendors for your commitment to innovation, learning, and progress for patients. We are #FasterTogether!
-
-
Over the last five years #GBMAGILE, a first of its kind clinical trial for patients with #glioblastoma, has achieved significant milestones through the collaborative efforts of numerous individuals, ongoing support from partnerships, and a community driven to improve treatment options. We are #fastertogther, united and determined to maximize learning from every patient; we will continue to make progress in our fight against GBM.
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-